Kaplan-Meier survival analysis confirmed the prognostic value of FZD2, showing that high FZD2 expression correlates with unfavorable overall survival (OS) and disease-free survival (DFS) in multiple cancers, particularly in STAD. This evidence concerns the gene FZD2 and gastric adenocarcinoma.